Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Psoriasis
Related studies linked through entity extraction aliases.
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- N/A
Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis
- Status
- WITHDRAWN
- Phase
- N/A
Modified Intermittent Fasting in Psoriasis
- Status
- COMPLETED
- Phase
- NA
SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
- Status
- WITHDRAWN
- Phase
- PHASE4
Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Taltz in Combination With Enstilar for Psoriasis
- Status
- RECRUITING
- Phase
- PHASE4
Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
How Does Patients' Overall Assessment of Their Health Vary Across and Within Different Disease Groups?
- Status
- UNKNOWN
- Phase
- N/A
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
- Status
- RECRUITING
- Phase
- PHASE4
Serum Level of IL31,33 and 36 in Egyptian Paients With Psoriasis
- Status
- UNKNOWN
- Phase
- N/A
Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants
- Status
- COMPLETED
- Phase
- PHASE1
Work Stress and Impact of Pruritus on Quality of Life
- Status
- COMPLETED
- Phase
- N/A
Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis
- Status
- TERMINATED
- Phase
- PHASE3
Evaluating of New Screening Tool for Arthritis* in Psoriasis
- Status
- COMPLETED
- Phase
- N/A
The Anti-inflammatory Effects of Harkány Medicinal Water
- Status
- UNKNOWN
- Phase
- NA